Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 3

Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection

Pages
532–535
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Dirui strips evaluated in this study seem to have a lower sensitivity than suggested and excess number of false negatives seems to limit utility of these strips.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Increased urine albumin excretion is suggested to be an early marker of glomerular damage.
📊
Key Findings & Data:Evaluation of a test’s performance characteristics such as diagnostic sensitivity and specifictiy is a necessity before application into routine practice.
💡
Conclusion & Impact:Dirui strips evaluated in this study seem to have a lower sensitivity than suggested and excess number of false negatives seems to limit utility of these strips.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Increased urine albumin excretion is suggested to be an early marker of glomerular damage. Evaluation of a test’s performance characteristics such as diagnostic sensitivity and specifictiy is a necessity before application into routine practice. To our knowledge up to now there is no study evaluating Dirui test strips for albuminuria determination. Therefore the objective of this study was to test these strips for agreement with the established method used in our routine laboratory. Freshly collected 177 urine specimens were included in the study. Strips were read on instruments Dirui H-500 and Dirui H-800 using reflectance photometry. For DiruiH13-Cr strip albumin to creatinine ratio (ACR) and for DiruiH12-800MA strip albumin determinations were compared with the analyses performed using immunoturbidimetry and kinetic Jaffe method. Sensitivity values for estimated ACR using DiruiH13-Cr strip and albumin concentration using DiruiH12-800MA strip were calculated as 80%, 72%, respectively. Specificity values were as; 71% for Dirui H13-Cr strip and 78% for Dirui H12-800MA strip. Screening tests using urine test strips should be validated before acceptance in the routine use. Dirui strips evaluated in this study seem to have a lower sensitivity than suggested and excess number of false negatives seems to limit utility of these strips.

🔖

Cite This Article

AKBULUT, E. D., KARADAĞ, M. E., YILMAZ, F. M. (2018). Evaluation of Dirui® H13-Cr and H12-800MA strips for albuminuria detection. Medicine Science, Cilt: 7 - Sayı: 3, 532–535. https://ajindex.com/articles/277208

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:1-150. American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care. 2013;36:11-66.
  2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 200113;414:782-7.
  3. Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7:35-43.
  4. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110:32-5.
  5. Miller WG, Bruns DE, Hortin GL, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem. 2009;55:24-38.
  6. Lippi G, Becan-McBride K, Behulova D, et al. Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med. 2013;51:229-41. National Kidney Foundation. Kidney disease outcomes quality inıtiative. clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Diseases. 2007;49:42-61. Wong HB LG. Measures of diagnostic accuracy: Sensitivity, specificity, PPV and NPV. Proceedings of Singapore Healthcare. 2011;20:316-8.
  7. Altman DG, Bland JM. Diagnostic tests. 1: Sensitivity and specificity. BMJ. 1994;308:1552. J Am Soc Nephrol. 2003/06/24 edition 2003. Prevalence of kidney damage in Australian adults: The AusDiab kidney study; p. S131-8. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-47.
  8. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275-84.
  9. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51:373-84.
  10. Lamb EJ, Levey AS, Stevens PE. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution. Clin Chem. 2013;59:462-5. National Institute for Health and Care Excellence. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. NICE clinical guideline 73. Manchester, United Kingdom. Nati